Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/11/2025

Management of Fever and Chills in Brucellosis

Understanding the Symptoms

  • Fever with temperature swings accompanied by profuse sweating, especially in the afternoon, is a hallmark symptom of brucellosis and may persist during early treatment 1
  • Chills frequently accompany the fever pattern in brucellosis and are part of the natural disease course 1
  • These symptoms typically represent the ongoing inflammatory response to the infection rather than adverse effects of the medications 2, 3

Assessment of Current Treatment

  • The doxycycline-rifampin combination is a first-line regimen for brucellosis with Grade AI recommendation, as recommended by the Infectious Diseases Society of America 4, 5
  • Standard dosing is doxycycline 100 mg twice daily for 6 weeks plus rifampin 600-900 mg daily as a single morning dose for 6 weeks, according to the Centers for Disease Control and Prevention 5

Management Recommendations

  • Symptoms are mild to moderate and improving since treatment initiation, as suggested by the American College of Physicians 5
  • No evidence of focal disease complications, such as neurobrucellosis or endocarditis, as recommended by the Infectious Diseases Society of America 1
  • Consider treatment modification if symptoms are severe or worsening despite 7-10 days of therapy, as recommended by the Centers for Disease Control and Prevention 2, 5

Supportive Measures for Symptom Relief

  • Antipyretics such as acetaminophen can help manage fever and associated discomfort, as recommended by the American Academy of Family Physicians 5
  • Adequate hydration is important, especially during episodes of sweating, as suggested by the World Health Organization 2
  • Rest during symptomatic periods and gradual return to activities as tolerated, as recommended by the American College of Physicians 5

Monitoring Recommendations

  • Regular clinical assessment of symptom progression, with improvement expected within 7-14 days of treatment initiation, as recommended by the Infectious Diseases Society of America 5
  • Serologic testing may not be helpful for early treatment response assessment, as suggested by the Centers for Disease Control and Prevention 5

When to Consider Alternative Regimens

  • If symptoms persist or worsen after 2 weeks of therapy, consider switching to doxycycline-streptomycin or doxycycline-gentamicin regimen, as recommended by the European Society of Clinical Microbiology and Infectious Diseases 4, 5
  • Doxycycline-gentamicin offers comparable efficacy to doxycycline-streptomycin, with gentamicin given for 7 days, as suggested by the Infectious Diseases Society of America 5

Important Considerations

  • Full resolution of all symptoms may take several weeks even with appropriate therapy, as recommended by the American College of Physicians 5
  • Relapse rates of 5-15% are reported even with appropriate treatment, as suggested by the Centers for Disease Control and Prevention 5

When to Seek Immediate Medical Attention

  • Development of new neurological symptoms suggesting neurobrucellosis, as recommended by the Infectious Diseases Society of America 1
  • High fever unresponsive to antipyretics, as suggested by the World Health Organization 2
  • Development of new focal symptoms suggesting disease progression, as recommended by the European Society of Clinical Microbiology and Infectious Diseases 1